Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Venditti

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|January 31, 2018
Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study CohortMarco Falcone, Giusy Tiseo, Emanuele Durante-Mangoni, et al.
Journal of the American Heart Association|January 8, 2015
Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirinMarco Falcone, Alessandro Russo, Roberto Cangemi, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>Massimiliano De Angelis, Maria T Mascellino, Maria C Miele, et al.
Antibiotics (Basel, Switzerland)|September 30, 2020
Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?Valeria Bellelli, Guido Siccardi, Livia Conte, et al.
Expert Review of Anti-Infective Therapy|March 8, 2021
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectivesMassimo Andreoni, Matteo Bassetti, Salvatore Corrao, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics ComparedFrancesco Cogliati Dezza, Gabriele Arcari, Federica Alessi, et al.
Medicine|February 5, 2016
Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes: Results From a Prospective Cohort StudyMarco Falcone, Giusy Tiseo, Alessandro Russo, et al.
BMC Infectious Diseases|October 2, 2015
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care UnitGiancarlo Ceccarelli, Alessandra Oliva, Gabriella d'Ettorre, et al.
The New Microbiologica|April 11, 2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literatureAlessandra Oliva, Francesca Cancelli, Andrea Brogi, et al.
Clinical and Translational Gastroenterology|June 7, 2021
Low-Grade Endotoxemia and Thrombosis in COVID-19Alessandra Oliva, Vittoria Cammisotto, Roberto Cangemi, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|January 31, 2018
Risk Factors and Outcomes of Endocarditis Due to Non-HACEK Gram-Negative Bacilli: Data from the Prospective Multicenter Italian Endocarditis Study CohortMarco Falcone, Giusy Tiseo, Emanuele Durante-Mangoni, et al.
Journal of the American Heart Association|January 8, 2015
Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirinMarco Falcone, Alessandro Russo, Roberto Cangemi, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant <i>Klebsiella pneumoniae</i> and <i>Acinetobacter baumannii</i>Massimiliano De Angelis, Maria T Mascellino, Maria C Miele, et al.
Antibiotics (Basel, Switzerland)|September 30, 2020
Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in Patients with Influenza: Decision Trees May Help?Valeria Bellelli, Guido Siccardi, Livia Conte, et al.
Expert Review of Anti-Infective Therapy|March 8, 2021
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectivesMassimo Andreoni, Matteo Bassetti, Salvatore Corrao, et al.
Antibiotics (Basel, Switzerland)|July 27, 2022
Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics ComparedFrancesco Cogliati Dezza, Gabriele Arcari, Federica Alessi, et al.
Medicine|February 5, 2016
Hospitalization for Pneumonia is Associated With Decreased 1-Year Survival in Patients With Type 2 Diabetes: Results From a Prospective Cohort StudyMarco Falcone, Giusy Tiseo, Alessandro Russo, et al.
BMC Infectious Diseases|October 2, 2015
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care UnitGiancarlo Ceccarelli, Alessandra Oliva, Gabriella d'Ettorre, et al.
The New Microbiologica|April 11, 2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literatureAlessandra Oliva, Francesca Cancelli, Andrea Brogi, et al.
Clinical and Translational Gastroenterology|June 7, 2021
Low-Grade Endotoxemia and Thrombosis in COVID-19Alessandra Oliva, Vittoria Cammisotto, Roberto Cangemi, et al.
Pageof 23